about
Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancerMetformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis.Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).Changes of uterine blood flow after vaginal radical trachelectomy (VRT) in patients with early-stage uterine invasive cervical cancer.The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer.Epidemiological characteristics of ovarian cancer in Korea.Rsf-1 (HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma.Incidence of serous tubal intraepithelial carcinoma (STIC) by algorithm classification in serous ovarian tumor associated with PAX8 expression in tubal epithelia: a study of single institution in Japan.Endometrial cancer diagnosed by the presence of bone metastasis and treated with zoledronic Acid: a case report and review of the literature.Loss of AF-6/afadin induces cell invasion, suppresses the formation of glandular structures and might be a predictive marker of resistance to chemotherapy in endometrial cancerIncreased risk of second primary malignancies following uterine cancer: a population-based study in Taiwan over a 30-year periodTrends in the demographic and clinicopathological characteristics in Japanese patients with endometrial cancer, 1990-2010.Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms.Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer.Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.Drug screening and grouping by sensitivity with a panel of primary cultured cancer spheroids derived from endometrial cancerCA-125 cut-off value as a predictor for complete interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer.A dual PI3K/AKT/mTOR signaling inhibitor miR-99a suppresses endometrial carcinoma.Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancerGlasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer.Asian Society of Gynecologic Oncology (ASGO): a central platform against gynecologic cancers in Asia.The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumorigenesis.Unexpected tumor progression after conization for carcinoma in situ of the uterine cervix.Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20 patients.Ovarian cancer: risk factors, treatment and management.Endometrial carcinoma in high-risk populations: is it time to consider a screening policy?Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells.Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee.The emerging epidemic of estrogen-related cancers in young women in a developing Asian country.Risk of depression following uterine cancer: A nationwide population-based study.Metformin is associated with reduced cell proliferation in human endometrial cancer by inbibiting PI3K/AKT/mTOR signaling.Discrimination of malignant transformation from benign endometriosis using a near-infrared approach.Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study.Uterine endometrial carcinoma: 10 years' experience with long-term follow-up at a single Korean institution.Practical usefulness of atypical endometrial cell categories within the new classification of endometrial cytology when applied to conventional smears.Changes in Uterine Cancer Incidence Rates in Egypt.
P2860
Q28083257-A34EA650-1DA6-44D6-A93D-16B34166A677Q33804513-564E9D8E-6B8B-4699-8FB0-598604F64388Q33933054-5B8E6895-B53F-4E7E-AA6F-0CE59E0A2BE9Q34061954-E975AAB6-9E07-4112-90EC-5EF25E108071Q34091442-CBDB1394-F880-4458-84F3-769FB9EA546AQ34512446-4EACEFF0-042B-433B-ABEF-9C959777CA58Q34517726-C49BD686-CFF5-4379-B2B6-08685600914BQ34643587-918F34AB-1779-4BC5-B63C-927B28E11870Q34743857-59FB4373-12D6-4D53-8A4E-A3367A9D4E73Q34999907-F0AEA417-FD93-42D2-A3A5-AED583B2ADECQ35440276-A3DE718F-8283-4ADE-83B0-D911650CD4DAQ35626007-EA768539-66C9-4083-ADA3-2B1365151B3EQ36008845-85CD125C-0970-402D-8B77-C1EF375E474AQ36469640-D0CE1471-D277-4235-BF42-254D0F8CC6BCQ36530680-225B061D-72CD-478F-B9E4-B49A2CE0A756Q36608043-0B2D8403-0632-4BDF-A01B-2942D31ACF89Q36801208-F6FE0A20-19DF-49B4-8C2F-A986F69858F5Q36817490-273F1EB5-0414-41EA-A61F-A4B7F25E7F13Q36841237-A535312C-37EC-4344-A6BB-C222A171AF8FQ37007297-78C7C4FE-FD5E-44AD-9EBB-E60FA431ED57Q37045528-A213302B-1188-44E1-8BE2-9A3C55CA1359Q37248539-0DA4C096-5B8E-4658-BCBA-2721FA10ED2DQ37317321-A2E10FDD-CDD4-4158-83C5-6ACF944A3D06Q37702777-47DD585B-CD3C-448A-B6C7-DA9EDB93BA12Q37932053-24AA6B8E-CA33-4ECC-9C4D-DED4B23422BBQ37967414-6AE22167-7635-4411-9A60-A0F980E057E0Q38143316-C58FF901-EF58-4F1D-9753-BD5EB102B734Q38182148-4D459C60-2CEF-4E20-8379-FCB6FAF98557Q38609944-F814715A-7905-4D71-9A90-6F869F8D4A51Q40999646-5976E10F-0AC4-4B9B-AE31-ADA015752A59Q42700313-8946A334-5910-4DF6-A2A0-673D3596A421Q43537383-88CAB314-8B43-40F0-9BE4-C75A3AA19439Q48004530-DDCDF745-0966-4798-8875-17ECDAA7CA8BQ49576153-2DD414B5-3ABA-495F-8576-87336B8F7F10Q49875204-11361E60-A1C9-4436-AD77-4A709F1BFBCEQ53081124-BAA9B092-EE96-42DF-A704-893E1844C266Q53356928-9B26EB3B-2EB4-4550-B694-AC0C15266D49Q53675493-0816DE66-EF94-4C95-AF6C-66F90264E1F2Q55689599-59F40326-DC6B-4714-9C69-362238DBB9D2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current status of gynecologic cancer in Japan
@en
Current status of gynecologic cancer in Japan.
@nl
type
label
Current status of gynecologic cancer in Japan
@en
Current status of gynecologic cancer in Japan.
@nl
prefLabel
Current status of gynecologic cancer in Japan
@en
Current status of gynecologic cancer in Japan.
@nl
P2860
P356
P1476
Current status of gynecologic cancer in Japan
@en
P2093
Kimio Ushijima
P2860
P356
10.3802/JGO.2009.20.2.67
P577
2009-06-29T00:00:00Z